Search

everythinglearnresearchcommunity

for

Search:↓

CaBP1 and CaBP2 are important for continuous hearing by preventing inactivation of calcium currents in ear cells, with CaBP2 also able to restore hearing when reintroduced.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Double-stranded RNA helps regenerate hair follicles by increasing retinoic acid production and signaling.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Testosterone raises blood pressure and changes kidney protein levels.

Mice with alopecia areata had wider lymphatic vessels in their skin.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

MC-1R is present in skin cells and may help reduce inflammation.

Two new enzymes, PAD-R11 and PAD-R4, were cloned and showed activity, with PAD-R11 resembling epidermal enzymes.

Club-like receptors detect light touch but not whisking.

Overexpression of ALK2 in hair follicles disrupts skin development and slows wound healing.

Shorter GGC triplet repeats in the androgen receptor gene are linked to less hair loss in Han men.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

EPHA4 and Ephrin A3 are found in the skin of Aohan fine-wool sheep.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Mouse models help understand alopecia areata and find treatments.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

P2X₃-IR fibers are widespread in rat skin and likely help detect pain.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.